EN Hikma Ethics and compliance We are committed to high standards of ethical conduct and are active partners in several global initiatives Siggi Olafsson, Chief Executive Officer Our company was founded by Samih Darwazah with two guiding principles, quality and integrity. Over 40 years later, I am proud these two principles continue to serve as the foundation of our Hikma culture. Hikma is committed to compliance and strives to maintain an active and effective Corporate Compliance programme. Since the appointment of our first Chief Compliance Officer in 2010, we continue to evolve our Corporate Compliance programme to meet the changing needs of our business and the changing legal and regulatory environment in which we operate. Education and training Education is a key element of Hikma’s Corporate Compliance programme. We are committed to implementing programmes that effectively train our employees on company policies and procedures. The Corporate Compliance team employs a variety of training methods to communicate these requirements including classroom and computer-based training, as well as employee communications on select topics. We review and update our training programmes periodically, and seek on an on-going basis to identify additional areas where training is needed. Communication We expect our employees, officers and directors to promptly report suspected or actual violations of our Corporate Compliance programme and laws and regulations governing our business. Hikma encourages reports to be made to a supervisor, manager, or directly to the Chief Compliance Officer or member of the Corporate Compliance department. We also maintain a hotline that allows for anonymous reporting of any compliance concerns and a process for investigating and documenting those concerns. To voice your concerns visit the Compliance Reporting Service: Click Here Responding to Potential Violations Potential violations of our Corporate Compliance programme are investigated with oversight by the company’s Corporate Investigations Committee which is comprised of the General Counsel, Chief Compliance Officer, and EVP Organizational Development. Disciplinary actions for violations are addressed in the Hikma Code of Conduct, and supporting policies. Hikma has a progressive disciplinary process up to and including termination of employment depending upon the severity of the violation. Disciplinary actions will be timely implemented to ensure that the incident is resolved and to prevent any potential reoccurrence. Oversight Our Chief Compliance Officer is a member of senior management, and responsible for the day-to-day management of Hikma’s Corporate Compliance Programme including drafting policies and procedures, training, auditing, monitoring, and conducting investigations. The Chief Compliance Officer provides periodic reports on the operation of the Corporate Compliance Programme to Hikma’s Executive Committee and the Corporate Responsibility and Ethics Committee (CREC), the body with ultimate authority over Hikma’s Corporate Compliance Programme responsible for assisting the Board of Directors in meeting their responsibilities as they relate to the compliance-related activities of the organization. Hikma’s Code of Conduct and Other Written Standards Focusing on quality and integrity have helped make Hikma the success it is today. By following the Code of Conduct, and behaving in a manner consistent with our values, we can maintain the trust of our colleagues, customers and ultimately the patients whom we serve. Read our code of conduct Auditing and Monitoring The Corporate Compliance function conducts auditing and monitoring activities designed to assess compliance with Hikma’s compliance-related policies, procedures and processes and identify needs. In addition, Hikma’s Board of Directors retains the services of an independent third party to conduct annual compliance audits of operations and a periodic evaluation of Hikma’s Corporate Compliance programme. Policies and Positions In addition to our Code of Conduct, Hikma has adopted compliance-related policies and procedures that provide detailed guidance and direction to employees on various compliance-related topics including, but not limited to, Anti-Bribery and Corruption, Anti-Money Laundering, Promotional Compliance, Healthcare Fraud and Abuse, Third-Party Due Diligence, Transparency Reporting, Modern Slavery, Conflicts of Interest, Sexual Harassment, Data Privacy and Protection Our policies and positions Latest news Hikma and Winterlight Labs collaborate to develop biomarkers for Schizophrenia patients in MENA 23 November 2021 Hikma Ventures invests in biotechnology company BioSapien Inc., developer of a patented drug-delivery device intended to reduce the system-wide side effects of chemotherapy treatments 11 November 2021 Hikma continues strong 2021 performance and reiterates full year guidance 4 November 2021 About Ethics and compliance Back to top Useful links About Products Investors News Careers Contact Worldwide Leadership Stay in touch Subscribe to our newsletter Follow us instagram Created with Sketch. © Hikma Pharmaceuticals PLC 2021 Terms of use Cookie policy Disclaimer Privacy policy Community guidelines Our website uses cookies to improve your experience. Some of the cookies we use are essential for parts of our website to operate. By using our website without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.